Predictive value of NLRC3 levels for pulmonary hypertension in patients with chronic obstructive pulmonary disease
Open Access
- 3 May 2024
- journal article
- research article
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (3) , 262-267
Abstract
Objectives: Chronic obstructive pulmonary disease (COPD) is a medical condition defined by persistent airflow limitation and respiratory symptoms caused by airway and/or alveolar abnormalities. Pulmonary hypertension (PH) is one of the cardiovascular comorbidities associated with COPD. We investigated the correlation of NLRC3 levels in patients with COPD with prognostic and surrogate parameters of PH on echocardiography and examined whether it could be used to predict PH in this patient population. Methods: A total of 80 patients diagnosed with COPD and 40 healthy volunteers as the control group were included in the study. The COPD group was further divided into two subgroups according to the systolic pulmonary artery pressure (sPAP) as follows: sPAP<35 mmHg and sPAP≥35 mmHg. The enzyme-linked immunosorbent assay (ELISA) method was used to determine the levels of NLRC3 in peripheral blood. Results: Patients with sPAP≥35 mmHg had a lower mean NLRC3 level than those with sPAP<35 mmHg (P=0.006). The NLRC3 levels showed a significant negative correlation with sPAP, tricuspid regurgitation velocity, right atrium, and pulmonary artery diameter. For NLRC3, the cut-off value was found to be 271,486 ng/L, with a sensitivity of 74%, and specificity of 63% in distinguishing patients with sPAP≥35 mmHg from all patients with sPAP<35 mmHg. Conclusions: Our study results suggest that NLRC3 levels measured from peripheral blood are predictive of PH in patients with COPD. Although the exact function of NLRC3 in the lungs, COPD, and PH have not been completely understood, we believe these findings will serve as a model for future studies.Keywords
This publication has 11 references indexed in Scilit:
- NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension DiagnosisAging and disease, 2018
- NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancerNature, 2016
- Pulmonary Hypertension in Chronic Lung DiseasesJACC, 2013
- NOD-Like Receptors in Lung DiseasesFrontiers in Immunology, 2013
- The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κBNature Immunology, 2012
- The Inflammasome NLRs in Immunity, Inflammation, and Associated DiseasesAnnual Review of Immunology, 2011
- Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertensionInternational Journal of Cardiology, 2010
- Update on pulmonary hypertension complicating chronic obstructive pulmonary diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2009
- NOD-Like Receptors: Role in Innate Immunity and Inflammatory DiseaseAnnual Review of Pathology: Mechanisms of Disease, 2009
- Pulmonary hypertension in COPDEuropean Respiratory Journal, 2008